Genesis Therapeutics

About Genesis Therapeutics

Genesis Therapeutics is a leading biotechnology company leveraging artificial intelligence to accelerate drug discovery, focusing on diseases with high unmet medical needs. The company's core platform, GEMS (Genesis Exploration of Molecular Space), integrates deep learning techniques with physics-based methods to design novel small-molecule drugs.

Platform and Technologies

The GEMS platform enables researchers to predict molecular properties with high accuracy, optimize lead compounds, and explore vast chemical space with unprecedented efficiency. By combining deep learning models with physics-based simulations, Genesis can identify drug targets and develop compounds with higher efficacy and lower toxicity.

Focus Areas

The company focuses on developing innovative therapies in oncology, fibrosis, and other serious conditions that lack effective treatment options. Genesis collaborates with major pharmaceutical companies to enhance drug pipelines and accelerate access to new treatments.

Partnerships and Collaboration

Genesis believes in the importance of strategic collaboration and works with industry partners to integrate its platform into existing drug discovery processes, helping to reduce costs and time required for drug development.